Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Autologous Hematopoietic Stem Cell Transplant”

667 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 667 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT06724237
What this trial is testing

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

Who this might be right for
Anaplastic Large Cell Lymphoma, ALK-NegativeFollicular Helper T-Cell LymphomaFollicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type+1 more
Eastern Cooperative Oncology Group 294
Testing effectiveness (Phase 2)Ended earlyNCT01699581
What this trial is testing

Assessment of Impact Nutritional Program During Autologous Stem Cell Transplant

Who this might be right for
Hodgkin's LymphomaMultiple MyelomaNon-Hodgkin's Lymphoma
Greg Monohan 35
Large-scale testing (Phase 3)Study completedNCT00329030
What this trial is testing

Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401)

Who this might be right for
Lymphoma, B-CellLymphoma, Large-Cell, ImmunoblasticLymphoma, Non-Hodgkin
National Heart, Lung, and Blood Institute (NHLBI) 224
Testing effectiveness (Phase 2)Study completedNCT00116467
What this trial is testing

Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia

Who this might be right for
Acute Myelogenous Leukemia
Cell Genesys 55
Large-scale testing (Phase 3)Active Not RecruitingNCT00644228
What this trial is testing

Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma

Who this might be right for
DS Stage I Multiple MyelomaDS Stage II Multiple MyelomaDS Stage III Multiple Myeloma
National Cancer Institute (NCI) 525
Testing effectiveness (Phase 2)WithdrawnNCT03168100
What this trial is testing

2017-03: A Single-Arm, Open-label Study of Anti-Signaling Lymphocytic Activation Molecule F7 (Anti-SLAMF7) Monoclonal Antibody (mAb) Therapy After Autologous Stem Cell Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
University of Arkansas
Testing effectiveness (Phase 2)WithdrawnNCT03328936
What this trial is testing

Study of Personalized Melphalan Dosing in the Setting of Autologous Transplant

Who this might be right for
Hematopoietic Cell Transplantation RecipientRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)UnknownNCT04896164
What this trial is testing

Randomized Trial of Curcumin to Reduce Mucositis in Autologous Transplant Setting

Who this might be right for
Oral Mucositis (Ulcerative)
Tata Memorial Centre 190
Testing effectiveness (Phase 2)Study completedNCT00024466
What this trial is testing

Chemotherapy, Vaccine Therapy, and Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

Who this might be right for
Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Testing effectiveness (Phase 2)Study completedNCT00342134
What this trial is testing

Immunological Mechanisms of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Institute of Neurological Disorders and Stroke (NINDS) 34
Large-scale testing (Phase 3)UnknownNCT00747877
What this trial is testing

High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Leeds Cancer Centre at St. James's University Hospital 460
Large-scale testing (Phase 3)Study completedNCT01109004
What this trial is testing

Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)

Who this might be right for
Multiple Myeloma
National Heart, Lung, and Blood Institute (NHLBI) 758
Not applicableStudy completedNCT05352789
What this trial is testing

Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey.

Who this might be right for
Haematological MalignancyBone Marrow Transplant ComplicationsStem Cell Transplant Complications+4 more
Nottingham University Hospitals NHS Trust 66
Not applicableStudy completedNCT04783038
What this trial is testing

Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaAutologous Stem Cell Transplant
Mayo Clinic 30
Not applicableStudy completedNCT00574626
What this trial is testing

Comparing Autologous Peripheral Blood Stem Cell to Bone Marrow Transplantation for Recurrent Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Nebraska 51
Not applicableLooking for participantsNCT04745221
What this trial is testing

Efficacy and Safety of Auto-FMT in Preventing aGVHD

Who this might be right for
Graft Versus Host Disease, Acute
The First Affiliated Hospital of Soochow University 100
Testing effectiveness (Phase 2)Study completedNCT00238433
What this trial is testing

Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
OHSU Knight Cancer Institute 37
Large-scale testing (Phase 3)Study completedNCT01767714
What this trial is testing

Evaluation of Plerixafor Plus G-CSF to Mobilize and Collect 5×10^6CD34+ Cells/kg in Non-Hodgkin's Lymphoma (NHL) Patients for Autologous Transplantation

Who this might be right for
Non-Hodgkin's Lymphoma
Sanofi 100
Not applicableStudy completedNCT04287595
What this trial is testing

Effect of Orange Aroma on Nausea, Vomiting and Anxiety During Autologous Stem Cell Transplantation

Who this might be right for
NauseaVomitingAnxiety State
Hacettepe University 70
Early research (Phase 1)Study completedNCT01163357
What this trial is testing

Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

Who this might be right for
Autologous Hematopoietic Stem Cell Transplant RecipientLoss of Chromosome 17pPlasma Cell Leukemia+2 more
City of Hope Medical Center 18
Load More Results